AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Palbenz 75 Capsule

Prescription Icon
Prescription Required

Marketer

Admac Pharma Ltd

Salt Composition

Palbociclib (75mg)

Overview Palbenz 75 Capsule

75 mg Palbenz capsules are indicated for metastatic estrogen receptor-positive, HER2-negative breast cancer, administered concomitantly with hormonal anti-cancer agents. Optimal absorption requires ingestion with food, consistently at the same time daily. Dosage and frequency are determined individually by your physician, based on your specific condition, and may vary. Strict adherence to the prescribed regimen is crucial; deviations can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only upon medical advice. Common adverse events include asthenia, alopecia, dermatological reactions, emesis, and diarrhea. Myelosuppression, potentially increasing infection risk, may occur; report fever, chills, weakness, bleeding, or epistaxis immediately. Dizziness may necessitate avoidance of driving and tasks requiring alertness. Prior to commencing therapy, disclose any pre-existing cardiac, hepatic, or renal conditions, as well as concomitant medications, particularly anti-infectives, to your physician. Numerous drug interactions are possible; inform your healthcare provider of all medications you are taking. Use during pregnancy or lactation is contraindicated; reliable contraception for both partners is essential throughout treatment.

Uses of Palbenz 75 Capsule

Malignant mammary tumor

Major Benefits of Palbenz 75 Capsule:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Palbenz 75 Capsules with food.

Common Side effects of Palbenz 75 Capsule:

  • Decreased blood cells (red cells, white cells, and platelets)
  • Fatigue
  • Hair loss
  • Rash
  • Vomiting
  • Diarrhea
  • Nausea
  • Decreased appetite
  • Infection
  • Decreased white blood cell count
  • Stomatitis (Inflammation of the mouth)
  • Anemia (low number of red blood cells)
  • Weakness
  • Fever

How to use Palbenz 75 Capsule:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Palbenz 75 Capsules with a meal.

How Palbenz 75 Capsule works:

Palbenz 75 Capsules are an anti-neoplastic agent. Their mechanism involves blocking cyclin-dependent kinases 4 and 6, key proteins in cellular signaling cascades that drive cell growth. This inhibition halts the cancerous cell cycle, effectively suppressing tumor development. The drug specifically targets estrogen receptor-positive breast cancers by interfering with their cell cycle progression.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Palbenz 75 Capsule lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Palbenz 75 Capsules during pregnancy poses a confirmed risk to the fetus. A physician might exceptionally prescribe it in life-threatening emergencies where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Palbenz 75 Capsule are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingUNSAFE

Driving ability may be impaired by Palbenz 75 Capsule, as it can induce fatigue in certain individuals. Operate machinery or vehicles with care if experiencing this effect.

KidneyKidneySAFE IF PRESCRIBED

Palbenz 75 Capsules pose no known risk to patients with kidney impairment; dosage modification is unnecessary.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Palbenz 75 Capsules; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Palbenz 75 Capsule :

NA

Facts to Know About Palbenz 75 Capsule

LabelValue
Pharmaceutical Classification Piperazine-pyridinyl derivatives
Potential for Dependence None.
Type of Medication Cancer therapies
Mechanism of Action CDK inhibitor

FAQs on Palbenz 75 Capsule

Benzopal 75 Capsules are an antineoplastic medication. This medication inhibits cyclin-dependent kinase inhibitor proteins. This inhibition reduces cancer cell proliferation and retards disease advancement.
Treatment length differs individually. The required treatment course will be determined by your physician, considering your health status, treatment response, and tolerance of any adverse effects. Your physician may reduce your dosage or halt treatment, either temporarily or permanently, should unacceptable side effects occur.
While many side effects associated with Palbenz 75 Capsule subside upon discontinuation, neutropenia is a known adverse reaction. This condition, characterized by a decrease in white blood cells, weakens the immune system, increasing infection susceptibility during treatment. This effect, however, is typically short-lived and resolves quickly after cessation of Palbenz 75 Capsule use.
Regular blood work is crucial because this medication can reduce your blood cell levels. These tests monitor Palbenz 75 Capsule's impact on your white blood cells, red blood cells, and platelets. Blood tests are required before each chemotherapy cycle, on day 15 of the first two cycles, and as needed based on your clinical status.
Palbenz 75 Capsule is typically administered once daily for three weeks, followed by a one-week treatment-free period, completing a full 28-day cycle. It should be taken with food at the same time every day. Capsules must be swallowed whole; do not break, crush, or chew them. Discard any damaged capsules. If vomiting occurs after ingestion, refrain from taking a replacement dose and resume the prescribed schedule.
Females capable of becoming pregnant, undergoing Palbenz 75 Capsule treatment, and their male partners must employ reliable contraception (for example, dual-protection methods like condoms and diaphragms). This contraceptive practice should continue throughout treatment and for a minimum of three weeks post-treatment for women. Males receiving Palbenz 75 Capsule treatment should utilize birth control for at least fourteen weeks following treatment cessation.
Treatment with Palbenz 75 Capsule may impact male reproductive capacity. Therefore, men should contemplate sperm banking before commencing this treatment.
Palbenz 75 Capsule can cause severe adverse reactions such as breathlessness, lightheadedness, fatigue, and abnormal bleeding (including nosebleeds). Fever, shivering, infection symptoms, and a rapid, erratic, or forceful pulse are also possible. Seek immediate medical attention or contact your physician if any of these occur.
Palbenz 75 Capsule
5,745
MRP 6,999
17% off